MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coffman, B. L.
Right arrow Articles by Tephly, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coffman, B. L.
Right arrow Articles by Tephly, T. R.

Vol. 59, Issue 6, 1464-1469, June 2001

Analysis of Opioid Binding to UDP-Glucuronosyltransferase 2B7 Fusion Proteins Using Nuclear Magnetic Resonance Spectroscopy

Birgit L. Coffman, William R. Kearney, Mitchell D. Green, Robert G. Lowery, and Thomas R. Tephly

Department of Pharmacology (B.L.C., M.D.G., T.R.T.) and Nuclear Magnetic Resonance Facility (W.R.K), College of Medicine, University of Iowa, Iowa City, Iowa; and PanVera Corp. Madison, Wisconsin (R.G.L)

The UDP-glucuronosyltransferase UGT2B7 is an important human UGT isoform that catalyzes the conjugation of many endogenous and exogenous compounds, among them opioids, resulting in the formation of D-glucuronides. The binding site of the aglycone is located in the N-terminal half of the protein. In this study, we demonstrate that the opioid binding site in UGT2B7 is within the first 119 amino-terminal amino acids. Two maltose binding protein fusion proteins, 2B7F1 and 2B7F2, incorporating the first 157 or 119 amino acids, respectively, of UGT2B7 were expressed in Escherichia coli and purified by affinity chromatography. NMR spectroscopy using one-dimensional spectra, the inversion recovery method, and the transferred nuclear Overhauser effect spectroscopy was used to study the binding properties of opioids to the fusion proteins. Morphine was found to bind at a single site within the first 119 amino acids and to undergo a conformational change upon binding, as demonstrated by transferred nuclear Overhauser effect spectroscopy. Dissociation constants were obtained for morphine, naloxone, buprenorphine, and zidovudine, and the results were confirmed by equilibrium dialysis determinations. Two possible opioid binding sites, based on the nearest neighbors from opioid binding to the µ-receptor and to cytochrome 2D6, are proposed.

Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
S. Takeda, Y. Kitajima, Y. Ishii, Y. Nishimura, P. I. Mackenzie, K. Oguri, and H. Yamada
INHIBITION OF UDP-GLUCURONOSYLTRANSFERASE 2B7-CATALYZED MORPHINE GLUCURONIDATION BY KETOCONAZOLE: DUAL MECHANISMS INVOLVING A NOVEL NONCOMPETITIVE MODE
Drug Metab. Dispos., August 1, 2006; 34(8): 1277 - 1282.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Finel, X. Li, D. Gardner-Stephen, S. Bratton, P. I. Mackenzie, and A. Radominska-Pandya
Human UDP-Glucuronosyltransferase 1A5: Identification, Expression, and Activity
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1143 - 1149.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
J. J. Engtrakul, R. S. Foti, T. J. Strelevitz, and M. B. Fisher
ALTERED AZT (3'-AZIDO-3'-DEOXYTHYMIDINE) GLUCURONIDATION KINETICS IN LIVER MICROSOMES AS AN EXPLANATION FOR UNDERPREDICTION OF IN VIVO CLEARANCE: COMPARISON TO HEPATOCYTES AND EFFECT OF INCUBATION ENVIRONMENT
Drug Metab. Dispos., November 1, 2005; 33(11): 1621 - 1627.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
J. A. Williams, R. Hyland, B. C. Jones, D. A. Smith, S. Hurst, T. C. Goosen, V. Peterkin, J. R. Koup, and S. E. Ball
DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
Drug Metab. Dispos., November 1, 2004; 32(11): 1201 - 1208.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
D. Zhang, W. Zhao, V. A. Roongta, J. G. Mitroka, L. J. Klunk, and M. Zhu
AMIDE N-GLUCURONIDATION OF MAXIPOST CATALYZED BY UDP-GLUCURONOSYLTRANSFERASE 2B7 IN HUMANS
Drug Metab. Dispos., May 1, 2004; 32(5): 545 - 551.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Girard, O. Barbier, G. Veilleux, M. El-Alfy, and A. Belanger
Human Uridine Diphosphate-Glucuronosyltransferase UGT2B7 Conjugates Mineralocorticoid and Glucocorticoid Metabolites
Endocrinology, June 1, 2003; 144(6): 2659 - 2668.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
T. Hirota, I. Ieiri, H. Takane, H. Sano, K. Kawamoto, H. Aono, A. Yamasaki, H. Takeuchi, M. Masada, E. Shimizu, et al.
Sequence Variability and Candidate Gene Analysis in Two Cancer Patients with Complex Clinical Outcomes During Morphine Therapy
Drug Metab. Dispos., May 1, 2003; 31(5): 677 - 680.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
B. L. Coffman, W. R. Kearney, S. Goldsmith, B. M. Knosp, and T. R. Tephly
Opioids Bind to the Amino Acids 84 to 118 of UDP-Glucuronosyltransferase UGT2B7
Mol. Pharmacol., February 1, 2003; 63(2): 283 - 288.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
G. R. Rios and T. R. Tephly
Inhibition and Active Sites of UDP-Glucuronosyltransferases 2B7 and 1A1.
Drug Metab. Dispos., December 1, 2002; 30(12): 1364 - 1367.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics